← Back to all trials
Completed
NCT04942834
Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation
Conditions: Atrial Fibrillation, Persistent, Arrhythmias, Cardiac
Sex: All
Ages: 18 Years – 75 Years
Healthy volunteers: No
Phase: NA
Enrollment: 320
Sponsor: Ruijin Hospital
Location: Fujian Provincial Hospital Fuzhou Fujian
Summary
This study is to assess the effectiveness and safety of using cryoballoon ablation comparing with anti-arrhythmic drug therapy as initial treatment for naive patients with persistent atrial fibrillation.
Eligibility Criteria
Inclusion Criteria:
* Documentation of symptomatic persistent AF: Defined as having a continuous episode lasting longer than 7 days but less than 1 year documented by consecutive ECG recordings OR Defined as having a continuous episode lasting longer than 7 days but less than 1 year documented by an ECG recording and one doctor note indicating patient had symptoms consistent with AF
* Age 18 -75 years old
* Structurally normal heart with LVEF ≥50%, interventricular septum thickness ≤ 12 mm, and left atrial diameter \
Source: ClinicalTrials.gov (NCT04942834). StuddyBuddy aggregates publicly available trial information.
